Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit) encodes the proteolytic core of the mitochondrial CLPXP protease complex, essential for mitochondrial protein quality control. CLPP degrades misfolded, oxidized, and regulatory proteins within the mitochondrial matrix. Mutations in CLPP cause Perrault syndrome (hearing loss with ovarian failure), and dysregulated CLPP function has been implicated in aging, neurodegeneration, and cancer. [1]
| Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit | |
|---|---|
| Gene Symbol | CLPP |
| Full Name | Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit |
| Chromosome | 19p13.3 |
| NCBI Gene ID | [81792](https://www.ncbi.nlm.nih.gov/gene/81792) |
| OMIM | [614922](https://www.omim.org/entry/614922) |
| Ensembl ID | ENSG00000139289 |
| UniProt ID | [Q9NZJ5](https://www.uniprot.org/uniprot/Q9NZJ5) |
| Protein Class | Mitochondrial protease (CLP family) |
| Associated Diseases | Perrault Syndrome, Hearing Loss, Ovarian Failure |
CLPP is a 473-amino acid mitochondrial matrix protease:
CLPP forms a hexadecameric ring structure (16 subunits) composed of two stacked 8-membered rings.
| Component | Function |
|---|---|
| CLPP | Proteolytic core, protein degradation |
| CLPX | AAA+ ATPase, unfoldase, substrate recognition |
| CLPA | Adaptor protein, regulation |
CLPXP degrades substrates with specific degrons:
CLPP is ubiquitously expressed with highest levels in:
CLPP maintains mitochondrial proteostasis:
CLPP regulates:
Under stress conditions:
Clinical Features:
| Feature | Description |
|---|---|
| Sensorineural hearing loss | Progressive, bilateral |
| Ovarian failure | Primary or secondary amenorrhea |
| Neurologic features | Ataxia, neuropathy (some cases) |
| Variable expressivity | Even within families |
Genetics:
Mechanism:
CLPP dysfunction implicated in:
CLPP deficiency leads to:
CLPP is the proteolytic core of the mitochondrial CLPXP protease complex, essential for mitochondrial protein quality control. Mutations cause Perrault syndrome with hearing loss and ovarian failure, while dysregulated CLPP contributes to neurodegeneration and cancer. Understanding CLPP biology provides insights into mitochondrial proteostasis and potential therapeutic targets.
Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.